Idgie Health review

Both molecules get a microdose product of their own here, each with its own page, its own heading and its own plan selector, described as a fractional approach meant to ease the introduction to the drug. Month to month, both undercut their standard counterparts, and each three-month plan prints the total charged today and states the saving in dollars — figures that add up when you check them, which is not something to take for granted. The pages also say plainly that microdosing is off-label and that compounded medications are not FDA-approved finished drug products, a caution most sellers bury in a footer if they print it at all. The catch is at the committed end. The microdose ladders stop at three months while the standard ladders run to six, and the six-month standard semaglutide rate comes in below the best microdose rate available — so a reader willing to commit half a year pays more for the smaller dose than for the larger one. No milligram is published for either microdose product, so fractional is the entire description, and the pharmacy is described by class rather than named.

Vs median

$35/mo below the $169 median across the 261 of 407 programs here that publish a plain monthly rate

Market

$59–$1,300/mo is the full published spread on this site

Structure

Charges less for less

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Varies by dose, plan or tier

Idgie Health says it uses a 503A pharmacy, but does not say which one. No bloodwork is required before you start. A clinician review is included in the price.

Idgie Health sells compounded semaglutide and tirzepatide in standard and microdose versions, each a separate product with its own page, its own heading and its own plan selector, alongside NAD+, B12, sermorelin and a hair and skin line. The microdose pages are headed low-dose GLP-1 and describe a fractional, provider-directed approach intended to soften the introduction to the drug. Each product offers a month-to-month plan and a three-month plan with the total charged up front and the saving stated in dollars. Compounding is described as a licensed United States 503A pharmacy, which is not named. The site states on the microdose pages themselves that microdosing is off-label and that compounded medications are not FDA-approved finished drug products.

ON SEMAGLUTIDE THE MICRODOSE IS THE MORE EXPENSIVE ROUTE IF YOU COMMIT: its best rung is $125 a month, while the standard product's six-month plan is $114 — so the smaller dose costs $11 a month more than the larger one

• The microdose ladders stop at three months while the standard ladders run to six, so the deeper discounts are available only on the full dose
• No milligram is published for either microdose product, so fractional is the entire description of the dose
• The compounding pharmacy is never named, only its class
• A LegitScript mark is displayed for pharmacies; a mark records an identifier issued to somebody and is not evidence about this seller
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

Idgie Health is one of 407 low-dose GLP-1 programs compared on this site, and 261 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• Microdosing semaglutide
• Microdosing tirzepatide
• What microdosing GLP-1 costs
• The true annual cost of a plan
• Microdose & reconstitution calculator